Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Neuropsychology Review
|
September 1, 1990
Cognitive habilitation in schizophrenia: a theoretical review and model of treatment
S Flesher
Psychiatry
|
August 1, 1995
The neurosociology of schizophrenia: vulnerability and functional disability
M Carter, S Flesher
Schizophrenia Bulletin
|
February 10, 2000
Developmental theory for a cognitive enhancement therapy of schizophrenia
G E Hogarty, S Flesher
Schizophrenia Bulletin
|
January 1, 1992
Cognitive remediation in schizophrenia: proceed ... with caution!
G E Hogarty, S Flesher
Schizophrenia Bulletin
|
February 10, 2000
Practice principles of cognitive enhancement therapy for schizophrenia
G E Hogarty, S Flesher
Amino Acids
|
January 1, 1999
Role of zinc in blockade of excitotoxic action of quinolinic acid by picolinic acid
K H Jhamandas, R J Boegman, R J Beninger, et al.
Health Services Research
|
December 14, 2002
The cost of doing business: cost structure of electronic immunization registries
John M Fontanesi, Don S Flesher, Michelle De Guire, et al.
British Journal of Pharmacology
|
March 1, 1996
Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid
A C Pawley, S Flesher, R J Boegman, et al.
The American Journal of Psychiatry
|
November 14, 1997
Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates
G E Hogarty, S J Kornblith, D Greenwald, et al.
The American Journal of Psychiatry
|
November 14, 1997
Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients
G E Hogarty, D Greenwald, R F Ulrich, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Neuropsychology Review
|
September 1, 1990
Cognitive habilitation in schizophrenia: a theoretical review and model of treatment
S Flesher
Psychiatry
|
August 1, 1995
The neurosociology of schizophrenia: vulnerability and functional disability
M Carter, S Flesher
Schizophrenia Bulletin
|
February 10, 2000
Developmental theory for a cognitive enhancement therapy of schizophrenia
G E Hogarty, S Flesher
Schizophrenia Bulletin
|
January 1, 1992
Cognitive remediation in schizophrenia: proceed ... with caution!
G E Hogarty, S Flesher
Schizophrenia Bulletin
|
February 10, 2000
Practice principles of cognitive enhancement therapy for schizophrenia
G E Hogarty, S Flesher
Amino Acids
|
January 1, 1999
Role of zinc in blockade of excitotoxic action of quinolinic acid by picolinic acid
K H Jhamandas, R J Boegman, R J Beninger, et al.
Health Services Research
|
December 14, 2002
The cost of doing business: cost structure of electronic immunization registries
John M Fontanesi, Don S Flesher, Michelle De Guire, et al.
British Journal of Pharmacology
|
March 1, 1996
Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid
A C Pawley, S Flesher, R J Boegman, et al.
The American Journal of Psychiatry
|
November 14, 1997
Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates
G E Hogarty, S J Kornblith, D Greenwald, et al.
The American Journal of Psychiatry
|
November 14, 1997
Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients
G E Hogarty, D Greenwald, R F Ulrich, et al.
Page
of 2